![]() ![]() ![]() While we believe the majority of these elevated supply chain costs are temporary, we do not expect them to return to normalized levels this fiscal year. Recently, these pressures have rapidly escalated and we are experiencing significantly elevated product costs due to international freight and commodities. Our Medical segment continues to be impacted by the disruptions in the global supply chain that we called out last quarter. We believe our Pharma business, inclusive of our strategic growth areas of Specialty, Nuclear and Outcomes, is well positioned for growth in FY '22 and beyond. In Pharma, we continue to see sequential volume improvement and are encouraged by the profit growth that we saw in the first quarter. As we continue to manage through the global pandemic, we're staying focused on the near-term priorities and long-term strategies to drive growth and momentum across our businesses. Our first quarter results were in line with our expectations. Thank you, Kevin and good morning, everyone. Michael Kaufmann - Chief Executive Officer With that, I'll now turn the call over to Mike. During the Q&A portion of today's call, we please ask that you try and limit yourself to one question, so that we can try and give everyone an opportunity. GAAP to non-GAAP reconciliations for all relevant periods can be found in the schedules attached to our press release. Please note that during our discussion today, our comments will be on a non-GAAP basis, unless they are specifically called out as GAAP. #CARDINAL CHAINS LEVEL 50 SOLUTION FULL#Please refer to our SEC filings and the forward-looking statement slide at the beginning of our presentation for a full description of these risks and uncertainties. The matters addressed in the statements are subject to the risks and uncertainties that could cause actual results to differ materially from those projected or implied. Joining me today are Mike Kaufmann, Chief Executive Officer and Jason Hollar, Chief Financial Officer.ĭuring the call, we will be making forward-looking statements. ![]() You can find today's press release and presentation on the IR section of our website at ir. Today, we will discuss Cardinal Health's first quarter fiscal 2022 results. Its inventory management solutions are currently used to track products in more than 2,700 hospital locations and 68 distribution locations in 41 countries.Good morning and welcome. The team is committed to expanding its offerings to bring additional benefits to health care providers and aims to develop new solutions that will accelerate the transfer and analysis of big data and support real-time decision making on issues such as consumption and impending product expiration.Ĭardinal Health continues to rapidly expand its automated inventory management offerings and solutions for challenging processes related to procedural areas, such as the operating room. The new center comprises hardware design, solutions testing laboratories as well as a customer experience center, where visitors can interact with integrated solutions and provide feedback on technologies and services in the development stages. Building on existing automated cloud-based supply chain solutions, Cardinal Health’s vision is to create a level of efficiency and connectivity that will transform the healthcare supply chain from a source of savings into a strategic asset that can significantly reduce the total cost of care.” “While much of healthcare’s IoT focus has centered on patient monitoring applications, we believe that medical devices are ripe for an IoT approach. “ IoT has gained significant traction in health care,” said Jean-Claude Saghbini, vice president and general manager for Cardinal Health Inventory Management Solutions. lab located in Concord, Mass., will serve as a hub for Cardinal Health to explore innovative approaches, such as smart sensors and near-field communication, to bring creative, acute care-centered technologies to some of health care’s most challenging issues. In an Internet of Things (IoT) approach to health care Cardinal Health announced the opening of its Healthcare Supply Chain Innovation Lab, a research and development facility dedicated to reducing the $5 billion in waste in the health care devices supply chain. Cardinal Health’s new lab will explore innovative approaches, such as smart sensors and near-field communication.Ĭardinal Health exec: “We believe that medical devices are ripe for an IoT approach.”Ĭardinal Health inventory management solutions are used to track products in 2,700 hospitals in 41 countries. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |